Celldex Therapeutics, Inc. · NASDAQ:CLDX
Wellington Management Group LLP reported a 7.90% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 12, 2025
Wellington Management Group LLP reported a 7.90% stake in Celldex Therapeutics, Inc., 5,232,326 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G/A).
- Stake
- 7.90%
- Shares
- 5,232,326
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 7.90% | 5,232,326 |
| Wellington Group Holdings LLP | 7.90% | 5,232,326 |
| Wellington Investment Advisors Holdings LLP | 7.90% | 5,232,326 |
| Wellington Management Company LLP | 7.70% | 5,232,326 |
Source
Related
- Celldex Therapeutics, Inc.
- Wellington Management Group LLP
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2026
- Schedule 13G/A · Wellington Management Group LLP · Nov 7, 2025
- Schedule 13G/A · Wellington Management Group LLP · May 12, 2025
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · May 15, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026